Opportunities for Supporting Best Practices in Patients with Prostate Cancer- Evaluate the clinical and economic burden of prostate cancer (PCa), including the effects of disease progression and sequelae. Discuss current and potential recommendations for PCa screening, early detection, and intervention, particularly in high-risk populations. Describe the biochemical and immunological basis for current and future PCa therapies. Outline the benefits and limitations of current and emerging PCa therapies used alone or in combination for castration-resistant prostate cancer (CRPC) treatment.
1.0 Free Contact Hours for Pharmacists
Expires 4/12/12